Bai Jiang Cao (Patrinia, Thiaspi)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Bai Jiang Cao?

  Roughly 9–15 g in decoction, consistent with standard materia medica ranges; higher doses within the traditional range are associated with the abscess indications. The part used is the whole plant with the root — our record gives the pharmaceutical Latin as Herba cum Radice Patriniae, i.e. aerial parts together with root. It is also applied externally, prepared as a decoction or poultice for sores and swellings.

  • 9–15 g in decoction internally.
  • Part used: whole plant including root.
  • External use: topical application for carbuncles and sores.

  Source: Sacred Lotus sources & references (existing dosage and identity records); standard materia medica ranges. Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Bai Jiang Cao?

  Do not use in Spleen and Stomach deficiency, and note that over-dosage may cause nausea or dizziness — both are recorded in Sacred Lotus's own reference data and are echoed in the modern review literature. A comprehensive review of Herba Patriniae reports that toxicity is minimal at clinical doses, but that excessive dosing has been associated with temporary leukopenia, dizziness and nausea (PMID 32846192).

  • Spleen and Stomach deficiency — avoid; the herb is cold and dispersing.
  • Excessive dose — nausea, dizziness, and transient leukopenia reported (PMID 32846192). Stay within the traditional range and use under a qualified practitioner.
  • Blood-moving action — because it disperses blood stasis, professional supervision is appropriate in pregnancy and in bleeding disorders; precautionary reference note.
  • Species identity — a documented substitution issue affects what is sold under this name (see below); authenticated material matters.

  Source: Sacred Lotus sources & references (traditional cautions); PMID 32846192. Neutral reference facts, not usage instructions.

Chinese Herb Toxicity & Overdose

• Low at clinical doses. A review of Herba Patriniae covering both principal source species concluded that toxicity remains minimal at clinical doses, with adverse effects — temporary leukopenia, dizziness and nausea — reported in association with excessive dosing (PMID 32846192). A broader review of the genus Patrinia notes that toxicity data are sparse and calls for better material identification and quality control (PMID 28595500). In other words: no established intrinsic toxicity, but a thin safety literature and a real authentication problem.

  Sources: PMID 32846192; PMID 28595500. Reference note, not a safety guarantee.

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented for Bai Jiang Cao. Two areas warrant practitioner awareness on precautionary grounds rather than evidence: its traditional blood-dispersing action alongside anticoagulant or antiplatelet therapy, and the report of transient leukopenia at excessive doses (PMID 32846192) alongside medications that suppress bone marrow. Neither is a demonstrated clinical interaction. Reviews of both the herb and the genus specifically note that pharmacokinetic research is insufficient (PMID 32846192, PMID 28595500), so interaction potential is genuinely under-studied rather than ruled out. (Flagged for practitioner confirmation.)

  Sources: PMID 32846192; PMID 28595500. Precautionary reference, not documented clinical interactions.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Bai Jiang Cao (Patrinia)?

  Yes — two substantial review-level surveys of the material exist, and the chemistry is well mapped even though clinical evidence is not. A review of Herba Patriniae identified 233 compounds across the two principal source species, dominated by triterpenoid saponins and flavonoids, and reported anti-inflammatory and antitumour activities in laboratory models; the two species showed comparable pharmacological profiles but differed biochemically, and the authors called for direct comparative study (PMID 32846192). A wider review of the genus Patrinia catalogued over 210 constituents — triterpenoids, saponins, iridoids and flavonoids — and recorded the traditional uses that match ours, including peri-appendicular abscess, lung carbuncle and dysenteric disorders, while stressing that clinical evidence is sparse (PMID 28595500).

  • Constituent classes — triterpenoid saponins, iridoids and flavonoids are the recurring actives across both reviews.
  • Reported activities — anti-inflammatory and antitumour effects predominate in the experimental literature. These are laboratory findings and do not establish a treatment.
  • Traditional indications are reflected in the literature — the genus review explicitly lists peri-appendicular abscess and lung carbuncle among the documented traditional uses, which lines up closely with the intestinal-abscess indication carried in our own record (PMID 28595500).
  • Evidence gaps — both reviews identify insufficient pharmacokinetic work and inadequate quality control as the main obstacles.

  Identity note — two different plants are sold as “Bai Jiang Cao.” The authentic material is Patrinia scabiosifolia or Patrinia villosa (family Caprifoliaceae, formerly Valerianaceae), which is what our Latin name Herba cum Radice Patriniae denotes. However, Thlaspi arvense (field pennycress, family Brassicaceae — an entirely unrelated plant) is widely traded under the same Chinese name and is explicitly described in the research literature as a misused species of Bai Jiang Cao; a 2025 comparative study found that although the Thlaspi material did show some antitumour activity in a colon-cancer model, it was less potent than genuine Patrinia scabiosifolia (PMID 40840726). The common name carried in our own record, “Patrinia, Thiaspi,” appears to carry this conflation forward (and spells the second name with an “i”). We have left our identity entries unchanged pending owner confirmation, and flag here that the two are not interchangeable and should not be treated as synonyms.

  Sources: PMID 32846192 (Journal of Ethnopharmacology, 2021, Herba Patriniae review — traditional uses, phytochemistry, pharmacology, quality control); PMID 28595500 (American Journal of Chinese Medicine, 2017, genus Patrinia review); PMID 40840726 (Journal of Ethnopharmacology, 2025, Patrinia scabiosaefolia versus the misused species Thlaspi arvense). Research context, not a therapeutic claim.

Chinese Herb Notes

• How is Bai Jiang Cao used in classical formulas?

  Its best-known classical appearance is in Yi Yi Ren Fu Zi Bai Jiang San, the Jin Gui Yao Lue formula for intestinal abscess — a short combination of Yi Yi Ren, Fu Zi and Bai Jiang Cao aimed at a chronic, less acutely hot presentation of intestinal abscess with pus. Bai Jiang Cao supplies the pus-expelling and stasis-dispersing action. In practice it is also commonly paired with other heat-clearing, toxin-resolving and blood-moving herbs for abscess and sore conditions. (Traditional formula context, not treatment advice — and note that Sacred Lotus's formula collection does not currently include this formula, so no cross-link is offered here.)

  What makes Bai Jiang Cao different from other toxin-resolving herbs?

  • It moves blood as well as clearing toxin — most herbs in the clear-heat-and-eliminate-toxins group do not disperse blood stasis. This dual action is why Bai Jiang Cao is reached for in abscess conditions where stasis and pus coexist, and why it also appears in stasis-type abdominal and menstrual pain.
  • It is spicy as well as bitter — the spicy flavour supports dispersing and moving, rather than only draining downward.
  • It is only slightly cold — less aggressively cooling than many of its category-mates, which suits the more chronic abscess presentations.
  • Its smell is diagnostic — the strong fermented-paste odour is a recognition feature of authentic material.

  Source: Sacred Lotus sources & references (herb identity and formula-link data), cross-referenced against multiple online sources and materia medica consensus.